Navigation Links
Former PhRMA President Billy Tauzin Joins Leading 340B Drug Administrator
Date:8/17/2011

SAN ANTONIO, Aug. 17, 2011 /PRNewswire-USNewswire/ -- Former Congressman and PhRMA CEO Billy Tauzin has joined the board of the pharmaceutical benefits management company CaptureRx. He will also serve as the company's Chief Industry Relations Officer.

Tauzin will work on behalf of CaptureRx, its hospital and health-center clients, and the national pharmacy networks that partner with the company. He will add his voice to initiatives that include identifying best practices and standardization of processes and reporting, and building relationships with managed care and federal and state agencies.

"Both clients of CaptureRx, a valued corporate member of our association, and the entire 340B community will be lifted by having someone of Mr. Tauzin's stature in our corner," said William von Oehsen, president of the Safety-net Hospitals for Pharmaceutical Access, the 340B trade association that represents more than 600 university and nonprofit hospital systems.

In 2004, Tauzin was diagnosed with a rare form of intestinal cancer.  "I was given less than a 1 percent chance of survival, but thanks to innovative drug therapies, I overcame the odds," he said. "I see my new role with CaptureRx as an opportunity to increase the access that underinsured folks have to these life-saving pharmaceuticals," said Tauzin, who served as Chief Executive Officer of the Pharmaceutical Research and Manufacturers for 5-1/2 years after leaving Congress.

Based in San Antonio, Texas, CaptureRx is a leader in administering a federal drug program called 340B, which lowers the cost of health care at zero cost to the government. Under the program, qualified hospitals and health centers purchase drugs for the program's patients at half the cost -- even less than Canadian drug prices.

This creates a safety net for much of the nation's under-insured and uninsured in an environment of looming federal deficits
'/>"/>

SOURCE CaptureRx
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Sunesis Pharmaceuticals to Present Interim Clinical Data From Voreloxin (Formerly SNS-595) Ovarian Cancer Trial at 44th ASCO Annual Meeting and Acute Myeloid Leukemia Trials at 13th EHA Congress
2. Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting
3. Sunesis Pharmaceuticals Focuses Resources on Development of Voreloxin (Formerly SNS-595)
4. Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association
5. Michigan Life Science and Innovation Center Opens in Former Pfizer Facility
6. Peregrine Pharmaceuticals Appoints Former Genentech Senior Executive Dr. Robert Garnick as Head of Regulatory Affairs
7. NGM Biopharmaceuticals Appoints Dr. Arthur D. Levinson, Former Genentech CEO, to its Board of Directors
8. Former Miss USA Shawnae Jebbia Shines with Siemens Pure
9. Secure eHealth, LLC Engages as a Consultant GSI Health Whose Principal and CEO is the Former Senior Advisor to National Coordinator for Health Information Technology
10. Former Air Force Surgeon General Joins Integrated Medical Systems Advisory Board
11. SCAI Statement on the Hospitalization of Former President Bill Clinton
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... , Sept. 3, 2015 ... Potentials of New Drugs, Industry Changes and Emerging ... the human ovaries? Visiongain,s new study forecasts those ... growth in that industry. You also explore trends, ... Our report gives revenue predictions to 2025 ...
(Date:9/3/2015)... NEW YORK , Sept. 3, 2015 /PRNewswire/ ... blood glucose device is a home-based electronic device. ... transmitter that transmits information about glucose levels through ... it is displayed. The regular usage of self-monitoring ... and prompt an individual to undergo proper diabetes ...
(Date:9/3/2015)... Sept. 3, 2015 Nevro Corp. (NYSE: ... providing innovative evidence-based solutions for the treatment of chronic ... at the Morgan Stanley Global Healthcare Conference on Thursday, ... Nevro management is scheduled to present at 11:45 ... live audio webcast, accessible in the "Investors" section of ...
Breaking Medicine Technology:Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 2Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 3Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 4Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 5Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 6Global Self-monitoring Blood Glucose Devices Market 2015-2019 2
... Karmanos Cancer,Institute physician-scientists today reported on two ... cancer at the American Association of Cancer ... Caucasian patients with endometrial or ovarian cancer, ... counterparts. Led,by Veronica Schimp, D.O., assistant professor ...
... Tanespimycin Shown to Have No Effect on QTc ... Kosan,Biosciences Incorporated today presented safety data from,preclinical and ... Serial electrocardiogram (ECG) monitoring,of patients was conducted in ... were conducted in more than 85,patients. Tanespimycin was ...
Cached Medicine Technology:Karmanos Physician-Scientists Examine Racial Disparities in,Patients with Gynecologic Cancer 2Karmanos Physician-Scientists Examine Racial Disparities in,Patients with Gynecologic Cancer 3Kosan Presents Data on Cardiac Safety Profile of Hsp90 Inhibitor,Tanespimycin (KOS-953) at AACR 2Kosan Presents Data on Cardiac Safety Profile of Hsp90 Inhibitor,Tanespimycin (KOS-953) at AACR 3Kosan Presents Data on Cardiac Safety Profile of Hsp90 Inhibitor,Tanespimycin (KOS-953) at AACR 4
(Date:9/4/2015)... ... September 04, 2015 , ... Georgia Insurance Advisors, ... a charity effort to provide for the family of Grace, a young local ... restrictive cardiomyopathy often leads to diastolic dysfunction – the inability to adequately move ...
(Date:9/4/2015)... ... 2015 , ... Keeping mold top of mind is important when considering indoor ... can grow anywhere - on carpet, clothing, food, paper, and even in places you ... in the home is key to preventing mold growth, which if exposed to can ...
(Date:9/4/2015)... ... September 04, 2015 , ... Bio-Logic Aqua® Research, ... devices, announced its only mission and research focus: Water Life Science®. In the ... body water evaporation is becoming dangerously accelerated. As a result of the global ...
(Date:9/4/2015)... NY (PRWEB) , ... September 04, 2015 , ... Lalonde ... qualifying heat, and followed up with victory in the men’s 400 meters final, with ... Senior Track and Field Championships in San Jose, Costa Rica in August 2015. The ...
(Date:9/4/2015)... , ... September 04, 2015 , ... ... medical assistance company today announced that it has entered into a multi-year agreement ... signed an agreement to bridge the link between American healthcare, Jamaican healthcare and ...
Breaking Medicine News(10 mins):Health News:Georgia Insurance Advisors Inaugurates Charity Drive to Assist the Family of Young Local Girl Diagnosed with an Enlarged Heart 2Health News:Georgia Insurance Advisors Inaugurates Charity Drive to Assist the Family of Young Local Girl Diagnosed with an Enlarged Heart 3Health News:September is Mold Awareness Month 2Health News:September is Mold Awareness Month 3Health News:September is Mold Awareness Month 4Health News:Bio-Logic Aqua® Research Announces Water Life Science and Body Water Evaporation as Research Focus and Mission 2Health News:Bio-Logic Aqua® Research Announces Water Life Science and Body Water Evaporation as Research Focus and Mission 3Health News:Lalonde Gordon’s Recipe Brings Home the Gold 2Health News:Lalonde Gordon’s Recipe Brings Home the Gold 3Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 2Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 3Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 4Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 5Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 6
... one in 500 Swedes carry a genetic mutation which can ... lifestyle changes, but quality of life can be maintained with ... the Sahlgrenska Academy at the University of Gothenburg, Sweden. ... children and adolescents is the heart muscle disease hypertrophic cardiomyopathy. ...
... its inception in 1998, TCAG has provided world-leading infrastructure ... of genomic disciplines, from human health to agriculture, food, ... based at The Hospital for Sick Children, is located ... including:, Gene and genome sequencing Microarrays and genotyping ...
... 1 (HealthDay News) -- Loneliness can be harmful to a ... Researchers examined levels of loneliness and sleep quality among ... was socially isolated, but those who had higher loneliness scores ... often during the night and were deemed to have what ...
... By Serena Gordon HealthDay Reporter , TUESDAY, Nov. 1 ... United States dropped slightly, to 12.2 percent in 2009, from its ... March of Dimes. , But those numbers fall far short ... explained Dr. Jennifer Howse, president of the March of Dimes. ...
... Island Hospital examined how the perception of roles among ... web survey with embedded interventions, the researchers were able ... patient satisfaction, while staff reported changing or reconsidering how ... published in the European Journal of Emergency Medicine ...
... people in Uganda live with HIV/AIDS, where long ... to treatment. By employing an innovative mobile-technology strategy, ... Lawson Health Research Institute, hopes to provide a ... own a mobile device. By leveraging this common ...
Cached Medicine News:Health News:Research supports broader screening for sudden cardiac death 2Health News:Loneliness Linked to Sleepless Nights 2Health News: U.S. Preterm Birth Rate Down Slightly 2Health News: U.S. Preterm Birth Rate Down Slightly 3Health News:How staff perceptions of their roles impact patients experience in the emergency department 2Health News:How staff perceptions of their roles impact patients experience in the emergency department 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: